Codagenix Inc. logo

Codagenix Inc.

Design Platform for Vaccine & Oncolytic Virus development ~ COVID, Flu, RSV, Dengue, YF / Breast Cancer & Solid Tumors.

19 employees · est. 2011 · Farmingdale, United States

VS
HilleVax logo

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines.

76 employees · est. 2021 · Boston, United States

Codagenix Inc. is the older company (2011 vs 2021); HilleVax is the larger of the two.

Side-by-Side Comparison

Codagenix Inc. HilleVax
Founded
2011 older 2021
Headquarters
Farmingdale, United States Boston, United States
Employees
19 76 larger
Industry
Biotechnology Biopharma, Biotechnology, Health Care
Funding Stage
Grant Post Ipo Equity
Total Funding
$65.60M $235.00M
Funding Rounds
12 2
Services
live-attenuated virus design, vaccine development, genome editing, infectious disease solutions Not tracked yet
Target Customers
healthcare providers, biopharmaceutical companies, global health organizations, government health agencies Not tracked yet
Taxonomy
Vaccine Development, Live-Attenuated Vaccines, Oncolytic Virus Research, Synthetic Attenuated Virus Engineering, SAVE Technology, Viral Genome Engineering, Influenza Vaccine, RSV Vaccine, Dengue Vaccine, Synthetic Biology, Clinical Stage Biotechnology, Infectious Disease Research, Solid Tumor Oncolytics, Rational Vaccine Design Biopharmaceutical, Vaccine Development, Novel Vaccines, Virus-like Particle (VLP) Vaccine, Gastroenteritis Prevention, Norovirus, Biotech Startup, Healthcare Innovation, Biopharmaceutical Industry, Clinical Development, Commercialization, Medical Research, Bioengineering, Bioinnovation, Health Technology
Website
codagenix.com hillevax.com
Codagenix Inc. logo

About Codagenix Inc.

Codagenix Inc., founded in 2011, is a pioneering biotechnology company based in the United States, focused on revolutionizing vaccine and oncolytic virus development. Their proprietary platform, SAVE (Synthetic Attenuated Virus Engineering), uses sophisticated computer algorithms to create viral gen...

HilleVax logo

About HilleVax

HilleVax is a biopharmaceutical company founded in 2021 with a focus on the development and commercialization of novel vaccines. The company's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norov...

We will tell you when either one moves

BounceWatch watches Codagenix Inc. and HilleVax for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Codagenix Inc. and HilleVax — by email.

Frequently Asked Questions

Codagenix Inc. — Design Platform for Vaccine & Oncolytic Virus development ~ COVID, Flu, RSV, Dengue, YF / Breast Cancer & Solid Tumors.. HilleVax — HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Codagenix Inc. has raised $65.60M while HilleVax has raised $235.00M.
Codagenix Inc. and HilleVax operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Codagenix Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Codagenix Inc. on 9 Jun 2026, and HilleVax on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy